2022
Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control
Mouchati C, Kamari V, Sattar A, Yu J, McComsey G. Comprehensive assessment of neurocognitive function, inflammation markers, and adiposity in treated HIV and control. Medicine 2022, 101: e31125. PMID: 36281153, PMCID: PMC9592384, DOI: 10.1097/md.0000000000031125.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusImmunodeficiency virusNeurocognitive impairmentUndetectable HIV-1 RNA levelsHIV-1 RNA levelsHigh inflammatory markersMarkers of inflammationBody fat compositionVisceral adipose tissueCross-sectional studyBody composition measuresChi-square testHigher total fatInflammatory markersInflammation markersCentral adiposityHIV statusImmune activationInsulin resistanceMean agePLWHHeroin useAdipose tissueDrug AdministrationNeurocognitive function
2019
Brief Report: Zinc Supplementation and Inflammation in Treated HIV.
Dirajlal-Fargo S, Yu J, Kulkarni M, Sattar A, Funderburg N, Barkoukis H, Mccomsey G. Brief Report: Zinc Supplementation and Inflammation in Treated HIV. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2019, 82: 275-280. PMID: 31609926, PMCID: PMC6812547, DOI: 10.1097/qai.0000000000002129.Peer-Reviewed Original ResearchConceptsZinc supplementationZinc levelsDouble-arm studyHigh-dose armLow-dose armMedian zinc levelStable antiretroviral therapyMarkers of inflammationYears old peopleTreated HIVAntiretroviral therapyHIV infectionMedian ageClinical comorbiditiesBiomarker levelsMonocyte activationLarge effect sizesHIVInflammationPilot studyPhase ISupplementationDlElemental zincAfrican Americans